What Is the Meaning of Homocysteine in Patients on Dialysis?

Byham-Gray, 2005, Outcomes research in nutrition and chronic kidney disease: perspectives, issues in practice, and processes for improvement, Adv Chronic Kidney Dis, 12, 96, 10.1053/j.ackd.2004.10.012 Kalantar-Zadeh, 2003, Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences, Am J Kidney Dis, 42, 864, 10.1016/j.ajkd.2003.07.016 Suliman, 2007, The reverse epidemiology of plasma total homocysteine as a mortality risk factor is related to the impact of wasting and inflammation, Nephrol Dial Transplant, 22, 209, 10.1093/ndt/gfl510 Jamison, 2007, Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial, JAMA, 298, 1163, 10.1001/jama.298.10.1163 Wrone, 2001, An MTHFR variant, homocysteine, and cardiovascular comorbidity in renal disease, Kidney Int, 60, 1106, 10.1046/j.1523-1755.2001.0600031106.x Arnadottir, 1996, The effect of reduced glomerular filtration rate on plasma total homocysteine concentration, Scand J Clin Lab Invest, 56, 41, 10.3109/00365519609088586 Moustapha, 1999, Prevalence and determinants of hyperhomocysteinemia in hemodialysis and peritoneal dialysis, Kidney Int, 55, 1470, 10.1046/j.1523-1755.1999.00378.x Kang, 1997, Hyperhomocysteinemia as a risk factor for occlusive vascular disease, Annu Rev Nutr, 12, 279, 10.1146/annurev.nu.12.070192.001431 Van Guldener, 2006, Why is homocysteine elevated in renal failure and what can be expected from homocysteine-lowering?, Nephrol Dial Transplant, 21, 1161, 10.1093/ndt/gfl044 Van Guldener, 2001, Homocysteine metabolism in renal failure, Kidney Int, 78, 234, 10.1046/j.1523-1755.2001.59780234.x Kalantar-Zadeh, 2003, Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients, Kidney Int, 63, 793, 10.1046/j.1523-1755.2003.00803.x Kopple, 2005, The phenomenon of altered risk factor patterns or reverse epidemiology in persons with advanced chronic kidney failure, Am J Clin Nutr, 81, 1257, 10.1093/ajcn/81.6.1257 Suliman, 2000, Hyperhomocysteinemia, nutritional status, and cardiovascular disease in hemodialysis patients, Kidney Int, 57, 1727, 10.1046/j.1523-1755.2000.00018.x Suliman, 2001, Hyperhomocysteinemia in chronic renal failure patients: relation to nutritional status and cardiovascular disease, Clin Chem Lab Med, 39, 734, 10.1515/CCLM.2001.122 Suliman, 2003, Hyperhomocysteinemia and its relationship to cardiovascular disease in ESRD: influence of hypoalbuminemia, malnutrition, inflammation, and diabetes mellitus, Am J Kidney Dis, 41, 89, 10.1053/ajkd.2003.50093 Kalantar-Zadeh, 2004, A low, rather than a high, total plasma homocysteine is an indicator of poor outcome in hemodialysis patients, J Am Soc Nephrol, 15, 442, 10.1097/01.ASN.0000107564.60018.51 Nurmohamed, 2005, Reverse epidemiology: paradoxical observations in hemodialysis patients, Neth J Med, 63, 376 Balakrishnan, 2007, Cardiovascular and survival paradoxes in dialysis patients. Genetics and reverse epidemiology among patients on chronic hemodialysis, Semin Dial, 20, 570, 10.1111/j.1525-139X.2007.00361.x Friedewald, 1972, Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge, Clin Chem, 18, 499, 10.1093/clinchem/18.6.499 Daugirdas, 1993, Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error, J Am Soc Nephrol, 4, 1205, 10.1681/ASN.V451205 Frisancho, 1981, New norms of upper limb fat and muscle areas for assessment of nutritional status, Am J Clin Nutr, 34, 2540, 10.1093/ajcn/34.11.2540 Durnin, 1974, Body fat assessed from total body density and its estimation from skinfold thickness: measurement on 481 men and women aged from 16 to 72 years, Br J Nutr, 32, 77, 10.1079/BJN19740060 Kalantar-Zadeh, 1999, A modified quantitative subjective global assessment of nutrition for dialysis patients, Nephrol Dial Transplant, 14, 1732, 10.1093/ndt/14.7.1732 Chiarello, 2003, Hyperhomocysteinemia and oxidative stress in hemodialysis: effects of supplementation with folic acid, Int J Vitam Nutr Res, 73, 431, 10.1024/0300-9831.73.6.431 Schaeffner, 2003, Cholesterol and the risk of renal dysfunction in apparently healthy men, J Am Soc Nephrol, 14, 2084, 10.1681/ASN.V1482084 Appel, 2004, Dyslipidemia in chronic kidney disease and end-stage renal disease: a review, Dial Transplant, 33, 714 Stenvinkel, 2004, Role of inflammation in malnutrition and atherosclerosis in chronic renal failure, 199 Akgul, 2008, Low total plasma homocysteine level in relation to malnutrition, inflammation, and outcome in hemodialysis patients, J Ren Nutr, 18, 338, 10.1053/j.jrn.2007.11.007 Mezzano, 2001, Inflammation, not hyperhomocysteinemia, is related to oxidative stress and hemostatic and endothelial dysfunction in uremia, Kidney Int, 60, 1844, 10.1046/j.1523-1755.2001.00998.x Bayes, 2003, Homocysteine, C-reactive protein, lipid peroxidation and mortality in haemodialysis patients, Nephrol Dial Transplant, 18, 106, 10.1093/ndt/18.1.106 Ducloux, 2006, Impact of malnutrition-inflammation on the association between homocysteine and mortality, Kidney Int, 69, 331, 10.1038/sj.ki.5000096 Zoccali, 2006, Homocysteine and risk in end-stage renal disease: a matter of context, Kidney Int, 69, 204, 10.1038/sj.ki.5000078 Singhal, 1988, Determinants of serum creatine kinase activity in dialysis patients, Am J Nephrol, 8, 220, 10.1159/000167586